Medicine@Yale publication

Medicine@Yale.

January/February 2007   Volume 3 Issue 1

Inside this issue

Cover stories

Following in his father’s footsteps

$3 billion Yale campaign will benefit science and medicine

New genes found in Crohn’s disease, serious eye ailment

Partnerships

State makes first stem-cell grants to Yale

Grants & contracts

People

Lifelines: Joseph Schlessinger

Pediatric researcher is new ambassador for global health

Biologist cited for structural insights into action of antibiotics

Expert on blood pressure is honored

Education innovator wins award for work on transforming schools

Out & about

Awards & honors

Health

A robot arrives in the operating room

Science

A crystal-clear look at a puzzling protein

Magnetic resonance system will open new scientific vistas

Advances: In bacteria vs. worm, children are winners | Ruling fate of cellular blank slate | How the stressed become the depressed | The immune system in a sticky situation



image pdf icon

Download this issue in PDF format

Biologist cited for structural insights into action of antibiotics

Thomas Steitz

Thomas Steitz

In a ceremony and commemorative symposium held at Keio University in Tokyo in November, Thomas A. Steitz, Ph.D., Sterling Professor of Molecular Biophysics and Biochemistry at Yale, was awarded the 11th Keio Medical Science Prize.

Steitz, also a Howard Hughes Medical Institute investigator, was honored for X-ray crystallography research that in 2000 led to publication of the structure of the large subunit of the ribosome, which is crucially involved in translating instructions contained in messenger RNA (mRNA) into proteins.

Many antibiotics work by interfering with the translation of mRNA by the ribosome of bacteria, but some bacteria develop mutations that change the ribosome’s structure and render the bacteria resistant to treatment. From their crystallographic work, Steitz and collaborators have identified the structural basis of antibiotic drug function and resistance, and he and several Yale colleagues founded Rib-X, a company developing new compounds to combat drug-resistant bacteria.

The Keio award, the only prize of its kind awarded by a Japanese university, recognizes outstanding research achievements in the medical or life sciences, and includes an honorarium of 20 million Japanese yen, or about $173,000.

Steitz has been on the Yale faculty since 1970, arriving directly after completing postdoctoral training at Harvard University and at the Medical Research Council Laboratory in Cambridge, England.

The recipient of numerous awards, Steitz was appointed full professor in 1979 and named Sterling Professor in 2001. image

Jump to top.
Jump to top.

Copyright 2006, Yale University School of Medicine. All rights reserved. Email comments or suggestions to: editor@info.med.yale.edu